UniProt ID | Protein Name ▲ | Gene Symbol | No. of Glycosylation Sites | No. of GlyTouCan IDs | Disease Ontology |
---|---|---|---|---|---|
A0A669CA66 | ADAM metallopeptidase with thrombospondin type 1 motif 5 |
|
1 | 0 |
|
I3K2F6 | ADAM metallopeptidase with thrombospondin type 1 motif 5 |
|
1 | 0 |
|
A0A669CQ29 | Angiotensin-converting enzyme |
|
1 | 0 |
|
A0A669B7A7 | Angiotensin-converting enzyme |
|
3 | 0 |
|
A0A669EGC5 | Angiotensin-converting enzyme |
|
3 | 0 |
|
A0A669CV57 | Angiotensin-converting enzyme |
|
3 | 0 |
|
A0A669CZY5 | Angiotensin-converting enzyme |
|
3 | 0 |
|
I3KVB9 | Angiotensin-converting enzyme |
|
3 | 0 |
|
A0A669EFR8 | Angiotensin-converting enzyme |
|
3 | 0 |
|
I3KVC0 | Angiotensin-converting enzyme |
|
3 | 0 |
|
A0A669ELW2 | Angiotensin-converting enzyme |
|
1 | 0 |
|
A0A669D5R6 | Angiotensin-converting enzyme |
|
3 | 0 |
|
I3JPE6 | Cathepsin D |
|
2 | 0 |
|
Q6BD04 | G-protein coupled receptor 54 |
|
3 | 0 |
|
A0A669E5E8 | GDNF family receptor alpha-1 |
|
2 | 0 |
|
I3KHS4 | GDNF family receptor alpha-1 |
|
1 | 0 |
|
A0A669D192 | GDNF family receptor alpha-1 |
|
1 | 0 |
|
I3IZA7 | GDNF family receptor alpha-1 |
|
1 | 0 |
|
I3JZD2 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase |
|
1 | 0 |
|
I3J478 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase |
|
1 | 0 |
|
A0A669C867 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase |
|
1 | 0 |
|
I3J777 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase |
|
1 | 0 |
|
I3JCS1 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase |
|
1 | 0 |
|
A0A669E4B7 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase |
|
1 | 0 |
|
A0A669C5V4 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase |
|
1 | 0 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024